United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $749,493,307.57
- Oct. 14, 2024
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Oct. 14, 2024 | CFO | 7,792 | $355.88 | Sell | $2,773,016.96 | |
Oct. 7, 2024 | CFO | 7,794 | $355.54 | Sell | $2,771,078.76 | |
Sept. 30, 2024 | CFO | 7,792 | $358.62 | Sell | $2,794,367.04 | |
Sept. 23, 2024 | CFO | 7,796 | $354.04 | Sell | $2,760,095.84 | |
Sept. 9, 2024 | CFO | 7,802 | $345.41 | Sell | $2,694,888.82 | |
Sept. 3, 2024 | CFO | 7,785 | $362.37 | Sell | $2,821,050.45 | |
Aug. 26, 2024 | CEO | 269 | $348.41 | Sell | $93,722.29 | |
Aug. 19, 2024 | CEO | 3,600 | $344.18 | Sell | $1,239,048.00 | |
Aug. 8, 2024 | CEO | 3,600 | $328.39 | Sell | $1,182,204.00 | |
Aug. 7, 2024 | COO | 25,000 | $323.38 | Sell | $8,084,500.00 | |
Aug. 6, 2024 | CEO | 3,600 | $325.45 | Sell | $1,171,620.00 | |
Aug. 2, 2024 | Director | 5,000 | $325.35 | Sell | $1,626,750.00 | |
Aug. 2, 2024 | CEO | 3,600 | $324.73 | Sell | $1,169,028.00 | |
July 30, 2024 | CEO | 3,600 | $337.40 | Sell | $1,214,640.00 | |
July 26, 2024 | CEO | 3,600 | $338.61 | Sell | $1,218,996.00 | |
July 24, 2024 | CEO | 3,600 | $334.00 | Sell | $1,202,400.00 | |
July 22, 2024 | CEO | 3,600 | $331.32 | Sell | $1,192,752.00 | |
July 18, 2024 | CEO | 3,600 | $331.79 | Sell | $1,194,444.00 | |
July 16, 2024 | CEO | 3,600 | $328.03 | Sell | $1,180,908.00 | |
July 12, 2024 | CEO | 3,600 | $324.97 | Sell | $1,169,892.00 | |
July 10, 2024 | CEO | 3,600 | $326.35 | Sell | $1,174,860.00 | |
July 8, 2024 | CEO | 3,600 | $317.05 | Sell | $1,141,380.00 | |
July 5, 2024 | CEO | 3,600 | $313.25 | Sell | $1,127,700.00 | |
July 3, 2024 | CEO | 3,600 | $312.48 | Sell | $1,124,928.00 | |
July 1, 2024 | CEO | 3,600 | $320.45 | Sell | $1,153,620.00 | |
June 27, 2024 | CEO | 3,600 | $316.62 | Sell | $1,139,832.00 | |
June 25, 2024 | Director | 266 | $318.58 | Sell | $84,742.28 | |
June 24, 2024 | CEO | 3,600 | $315.97 | Sell | $1,137,492.00 | |
June 21, 2024 | CEO | 3,600 | $313.91 | Sell | $1,130,076.00 | |
June 14, 2024 | CEO | 3,600 | $287.22 | Sell | $1,033,992.00 | |
June 13, 2024 | Director | 2,000 | $281.53 | Sell | $563,060.00 | |
June 12, 2024 | CEO | 3,600 | $281.19 | Sell | $1,012,284.00 | |
June 10, 2024 | CEO | 3,600 | $273.95 | Sell | $986,220.00 | |
June 7, 2024 | CEO | 3,600 | $277.13 | Sell | $997,668.00 | |
May 31, 2024 | CEO | 3,600 | $272.48 | Sell | $980,928.00 | |
May 28, 2024 | Director | 3,600 | $269.06 | Sell | $968,616.00 | |
May 23, 2024 | Director | 3,600 | $275.78 | Sell | $992,808.00 | |
May 21, 2024 | Director | 1,468 | $275.85 | Sell | $404,947.80 | |
May 16, 2024 | Director | 3,600 | $272.37 | Sell | $980,532.00 | |
May 14, 2024 | Director | 1,310 | $264.35 | Sell | $346,298.50 | |
May 13, 2024 | CEO | 3,600 | $265.48 | Sell | $955,728.00 | |
May 9, 2024 | CEO | 3,600 | $264.22 | Sell | $951,192.00 | |
May 6, 2024 | CEO | 3,600 | $259.70 | Sell | $934,920.00 | |
May 3, 2024 | Director | 2,240 | $259.91 | Sell | $582,198.40 | |
May 2, 2024 | CEO | 3,600 | $258.09 | Sell | $929,124.00 | |
April 30, 2024 | CEO | 3,600 | $235.35 | Sell | $847,260.00 | |
April 26, 2024 | CEO | 3,600 | $235.20 | Sell | $846,720.00 | |
April 24, 2024 | CEO | 3,600 | $238.81 | Sell | $859,716.00 | |
April 22, 2024 | CEO | 3,600 | $236.47 | Sell | $851,292.00 | |
April 18, 2024 | CEO | 3,600 | $237.91 | Sell | $856,476.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, Nilda Mesa, James Edgemond, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Ray Kurzweil, Paul A. Mahon, DWEK RAYMOND, MAHON PAUL A, Louis Sullivan, R Paul Gray, Judy D. Olian, Tommy G. Thompson, and Michael Benkowitz
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on Oct. 14, 2024.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $8,084,500.00 on Aug. 7, 2024.